Influenza B Virus, Tokio 53/99, Inactivated

Catalog No : USB-209031
473.58€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Influenza B Virus, Tokio 53/99, Inactivated
Catalog No USB-209031
Supplier’s Catalog No 209031
Supplier US Biologicals
Source antigen Allantoic fluid of 10 day old embryonated eggs
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -20°C
Other names
Grade Purified
Purity ~90% (Ultracentrifugation with 10-40% sucrose gradient and inactivated)
Form Supplied as a sterile filtered liquid in 10mM Tris Hcl, 1mM EDTA, pH 8, 0.1M sodium chloride, 0.005% thimerosal, 0.09% sodium azide.
Reactivity life 12 months
Note For reserch purpose only
Purity ~90% (Ultracentrifugation with 10-40% sucrose gradient and inactivated)
Description Influenza virus B is a genus in the virus family Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humans and seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus A as both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virion consists of a matrix protein+envelope+nucleoprotein complex+ nucleocapsid, and a polymerase complex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase. The Influenza B virus is 14648 nucleotides long and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope. Source: Influenza B Virus, strain Influenza B Virus Tokio 53/99, from Allantoic fluid of 10 day old embryonated eggs, inoculated with influenza B virus. Applications: Suitable for use in ELISA. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Inactivation: Thimerosal and beta propiolactone treatment Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.